GetTopicDetailResponse(id=4ccb36214c, topicName=boost, introduction=boost, content=null, image=null, comments=3, allHits=771, url=https://h5.medsci.cn/topic?id=3621, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=53015, tagList=[TagDto(tagId=53015, tagName=boost)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1780441, encodeId=25a41e80441eb, content=<a href='/topic/show?id=4ccb36214c' target=_blank style='color:#2F92EE;'>#boost#</a>, objectTitle= 醫(yī)美前沿解讀 | Skinbooster韓國(guó)研究-改善皮膚質(zhì)量的證據(jù) , objectType=article, longId=292170, objectId=fea32921e0d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fea32921e0d2, replyNumber=0, likeNumber=180, createdTime=2022-08-02, rootId=0, userName=ms9833124466084992, userId=fc342500110, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fea32921e0d2, moduleTitle= 醫(yī)美前沿解讀 | Skinbooster韓國(guó)研究-改善皮膚質(zhì)量的證據(jù) , moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=fea32921e0d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780440, encodeId=2edd1e804408d, content=<a href='/topic/show?id=4ccb36214c' target=_blank style='color:#2F92EE;'>#boost#</a>, objectTitle=醫(yī)美前沿解讀 | Skinbooster韓國(guó)研究-改善皮膚質(zhì)量的證據(jù), objectType=article, longId=209349, objectId=deee20934998, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=deee20934998, replyNumber=0, likeNumber=91, createdTime=2022-01-24, rootId=0, userName=ms9833124466084992, userId=fc342500110, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=deee20934998, moduleTitle=醫(yī)美前沿解讀 | Skinbooster韓國(guó)研究-改善皮膚質(zhì)量的證據(jù), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=deee20934998)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780439, encodeId=de511e80439a1, content=<a href='/topic/show?id=4ccb36214c' target=_blank style='color:#2F92EE;'>#boost#</a>, objectTitle=Eiger制藥宣布首例患者入組聚乙二醇化干擾素聯(lián)合Ritonavir-Boosted Lonafarnib的II期LIFT研究, objectType=article, longId=146130, objectId=8c0f14613063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c0f14613063, replyNumber=0, likeNumber=93, createdTime=2018-08-25, rootId=0, userName=ms9833124466084992, userId=fc342500110, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c0f14613063, moduleTitle=Eiger制藥宣布首例患者入組聚乙二醇化干擾素聯(lián)合Ritonavir-Boosted Lonafarnib的II期LIFT研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=8c0f14613063)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
